Engineering more stable, selectable marker-free autoluminescent mycobacteria by one step

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Yang, Feng ^a   Njire, Moses M ^a   Liu, Jia ^a   Wu, Tian ^a   Wang, Bangxing ^a   Liu, Tianzhou ^a   Cao, Yuanyuan ^a   Liu, Zhiyong ^a   Wan, Junting ^a   Tu, Zhengchao ^a   Tan, Yaoju ^b   Tan, Shouyong ^b   Zhang, Tianyu ^a  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b Guangzhou Chest Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VECTOR; INTEGRASE; PLASMID VECTOR; BACTERIAL PROTEIN; PHOTOPROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; CONTROLLED STUDY; DNA SEQUENCE; ESCHERICHIA COLI; GENE CASSETTE; GENE CONSTRUCT; GENETIC ENGINEERING; GENETIC RECOMBINATION; INTEGRASE GENE; LUMINESCENCE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROCESS DEVELOPMENT; ANIMAL; BACTERIUM TRANSFORMATION; DRUG DEVELOPMENT; ECONOMICS; ENZYMOLOGY; GENE VECTOR; GENETICS; METABOLISM; MOUSE; PLASMID; PROCEDURES;

ANIMALIA; CORYNEBACTERINEAE; MUS; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; BACTERIAL PROTEINS; DRUG DISCOVERY; GENETIC ENGINEERING; GENETIC VECTORS; INTEGRASES; KANAMYCIN RESISTANCE; LUMINESCENT PROTEINS; MICE; MYCOBACTERIUM TUBERCULOSIS; PLASMIDS; TRANSFORMATION, BACTERIAL;

EID: 84924365866     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119341     Document Type: Article

References (27)

1. WHO.Global tuberculosis report 2014. World Health Organization, Geneva, Switzerland. 2014. Available: http://www.who.int/tb/publications/global-report/en/.
2. Hoffner S. Unexpected high levels of multidrug-resistant tuberculosis present new challenges for tuberculosis control. Lancet. 2012; 380:1367-1369. doi: 10.1016/S0140-6736(12)61069-1 PMID: 22938756
3. WHO. Global tuberculosis report 2012. World Health Organization, Geneva, Switzerland. 2012.
4. Loewenberg S. India reports cases of totally drug-resistant tuberculosis. Lancet. 2012; 379: 205. PMID: 22272391
5. Victor TC, van Helden PD, Warren R. Prediction of drug resistance in M.tuberculosis: molecular mechanisms, tools, and applications. IUBMB Life. 2002; 53: 231-237. PMID: 12121001
6. van Rie, Warren AR, Mshanga I, Jordaan AM, van der Spuy GD, Richardson M, et al. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol. 2001; 39: 636-641. PMID: 11158121
7. Zhang T, Li SY, Nuermberger EL. Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy. PLoS One. 2012; 7:e29774. doi: 10.1371/ journal.pone.0029774 PMID: 22253776
8. Zhang T, Li SY, Converse PJ, Grosset JH, Nuermberger EL. Rapid, Serial, Non-invasive Assessment of Drug Efficacy in Mice with Autoluminescent Mycobacterium ulcerans Infection. PLoS Negl Trop Dis. 2013; 7(12): e2598. doi: 10.1371/journal.pntd.0002598 PMID: 24367713
9. Winson MK, Swift S, Hill PJ, Sims CM, Griesmayr G, Bycroft BW, et al. Engineering the luxCDABE genes from Photorhabdus luminescens to provide a bioluminescent reporter for constitutive and promoter probe plasmids and mini-Tn5 constructs. FEMS Microbiol Lett. 1998; 163: 193-202. PMID: 9673022
10. Springer B, Sander P, Sedlacek L, Ellrott K, Bottger EC. Instability and site-specific excision of integra-tion-proficient mycobacteriophage L5 plasmids: Development of stably maintained integrative vectors. Int J Med Microbiol. 2001; 290: 669-675. PMID: 11310445
11. Andreu N, Zelmer A, Sampson SL, Ikeh M, Bancroft GJ, Schaible UE, et al. Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase. J Antimicrob Chemother. 2013; 68: 2118-2127. doi: 10.1093/jac/dkt155 PMID: 23633686
12. Yang F, Tan Y, Liu J, Liu T, Wang B, Cao Y, et al. Efficient construction of unmarked recombinant mycobacteria using an improved system. J Microbiol Methods. 2014; 103:29-36. doi: 10.1016/j.mimet. 2014.05.007 PMID: 24873745
13. Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, Bennett LT, et al. New use of BCG for recombinant vaccines. Nature. 1991; 351: 456-460. PMID: 1904554
14. Cascioferro A, Boldrin F, Serafini A, Provvedi R, Palu G, Manganelli R. Xer site-specific recombination, an efficient tool to introduce unmarked deletions into mycobacteria. Appl Environ Microb. 2010; 76: 5312-5316. doi: 10.1128/AEM.00382-10 PMID: 20543044
15. Zhang T, Bishai WR, Grosset JH, Nuermberger EL. Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains. Antimicrob Agents Chemother. 2010; 54: 2806-2813. doi: 10.1128/AAC.00400-10 PMID: 20421401
16. Tan Y, Hu Z, Zhang T, Cai X, Kuang H, Liu Y, et al. Role of pncA and rpsA Gene Sequencing in Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates from Southern China. J Clin Microbiol. 2014; 52: 291-297. doi: 10.1128/JCM.01903-13 PMID: 24131688
17. Zheng H, Lu L, Wang B, Pu S, Zhang X, Zhu G, et al. Genetic basis of virulence attenuation revealed by comparative genomic analysis of Mycobacterium tuberculosis strain H37Ra versus H37Rv. PLoS One. 2008; 3: e2375. doi: 10.1371/journal.pone.0002375 PMID: 18584054
18. Horwitz MA, Harth G. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect Immun. 2003; 71: 1672-1679. PMID: 12654780
19. Zhang T, Zhang M, Rosenthal IM, Grosset JH, Nuermberger EL. Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection. Am J Respir Crit Care Med. 2009; 180: 1151-1157. doi: 10.1164/rccm.200905-0795OC PMID: 19729664
20. Snapper SB, Melton RE, Mustafa S, Kieser T, Jacobs WR Jr. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol. 1990; 4: 1911-1919.PMID: 2082148
21. Wards BJ, Collins DM. Electroporation at elevated temperatures substantially improves transformation efficiency of slow-growing mycobacteria. FEMS Microbiol. Lett. 1996; 145:101-105. PMID: 8931333
22. Malaga W, Perez E, Guilhot C. Production of unmarked mutations in mycobacteria using site-specific recombination. FEMS Microbiol Lett. 2003; 219: 261-268. PMID: 12620630
23. Huff J, Czyz A, Landick R, Niederweis M. Taking phage integration to the next level as a genetic tool for mycobacteria. Gene. 2010; 468:8-19. doi: 10.1016/j.gene.2010.07.012 PMID: 20692326
24. Saviola B, Bishai WR. Method to integrate multiple plasmids into the mycobacterial chromosome. Nucleic Acids Res. 2004; 32: e11. doi: 10.1093/nar/gnh005 PMID: 14718555
25. van Kessel JC, Hatfull GF. Recombineering in Mycobacterium tuberculosis. Nat Methods. 2007; 4: 147-152. PMID: 17179933
26. Jain P, Hsu T, Arai M, Biermann K, Thaler DS, Nguyen A, et al. Specialized transduction designed for precise high-throughput unmarked deletions in Mycobacterium tuberculosis. MBio. 2014; 5:e01245-14. doi: 10.1128/mBio.01245-14 PMID: 24895308
27. Rubin EJ, Akerley BJ, Novik VN, Lampe DJ, Husson RN, Mekalanos JJ. In vivo transposition of mari-ner-based elements in enteric bacteria and mycobacteria. Proc Natl Acad Sci U S A. 1999; 96: 1645-1650. PMID: 9990078